Axios AM

March 27, 2026
🌸 Happy Friday! Smart Brevity™ count: 1,581 words ... 6 mins. Thanks to Zachary Basu for orchestrating. Edited by Eileen Drage O'Reilly and Bill Kole.
🏛️ New overnight: Around 3 a.m. ET, a Senate voice vote passed a deal to fund much of the Department of Homeland Security, except for immigration enforcement operations. The funding package now goes to the House, which is expected to consider it today. Keep reading.
- ✈️ President Trump said he'll sign an order instructing the Homeland Security secretary to immediately pay TSA agents. Keep reading.
1 big thing: Vance's big role
Vice President JD Vance is preparing to take on the most important assignment of his career: steering U.S. efforts to end a war he'd been concerned about waging in the first place, Axios' Marc Caputo and Barak Ravid report.
- Why it matters: Vance has already had multiple calls with Israeli Prime Minister Benjamin Netanyahu, met Gulf allies about the war and been involved in indirect communications with the Iranians. He's expected to be the top U.S. negotiator in potential peace talks.
Vance was highly skeptical of Israel's rosy prewar assessment of how the war would unfold, and currently expects the war to continue for another few weeks, according to U.S. and Israeli sources.
- Vance advisers think some in Israel are trying to undermine the VP, possibly because they find him insufficiently hawkish. Israeli officials deny that.
- President Trump made Vance's role official in a Cabinet meeting yesterday, asking the VP to give an update on Iran, and noting that he was working with Steve Witkoff and Jared Kushner on the negotiations.

🔬 Zoom in: Vance's seniority in the administration and his well-documented opposition to open-ended conflicts overseas, White House officials say, make him a more attractive interlocutor for the Iranians than Witkoff and Kushner, who oversaw the two previous rounds of failed talks.
- Partly for those reasons, Witkoff recommended Vance as lead negotiator.
- "If the Iranians can't strike a deal with Vance, they don't get a deal. He's the best they're gonna get," a senior administration official said.
- Vance is prepared to "take his place onstage" — but only if and when direct negotiations commence, according to a White House official.
State of play: Trump extended his deadline for negotiations with Iran yesterday, as Pakistani, Egyptian and Turkish mediators keep trying to organize in-person talks.
- Iranian officials told the mediators they're still waiting for a green light from "top leadership." If such a summit happens, Vance could sit across the table from Iran's speaker of parliament, Mohammad Bagher Ghalibaf.
- The administration is also considering a major military escalation if diplomacy fails.
Between the lines: During the lead-up to war, Vance was one of the more skeptical internal voices, raising questions about its duration, purpose and impact on U.S. munitions stockpiles, sources say.
- Once Trump decided to go to war, though, Vance advocated for using overwhelming force to achieve victory as quickly as possible.
- Vance advisers say he's supportive of Israel, but is concerned about potential gaps between the U.S. and Israeli objectives as the war continues.
- 🪖 An Iraq War veteran, Vance told The Washington Post two days before bombs dropped on Tehran: "I do think we have to avoid repeating the mistakes of the past. I also think that we have to avoid over-learning the lessons of the past."
2. ⚖️ Judge's reprieve for Anthropic
A federal judge paused the Trump administration's designation of Anthropic as a supply chain risk, marking an early legal victory for the embattled company, Axios' Maria Curi reports.
- The preliminary injunction gives Anthropic relief from ongoing reputational damage and provides greater certainty for commercial partners, the company says. Keep reading.
⚡ Scoop: Altman told staff he tried to "save" Anthropic in Pentagon clash
- As Anthropic's negotiations with the Pentagon were collapsing, OpenAI CEO Sam Altman told employees he was trying to "save" his competitor, according to internal Slack messages seen by Axios' Maria Curi and Zachary Basu.
- At the same time, Altman privately vented that Anthropic CEO Dario Amodei had spent years trying to undermine him.
On Feb. 26, Altman sent an all-staff message saying OpenAI shared Anthropic's red lines and wanted to help de-escalate — while making clear he still hoped to strike his own deal with the Pentagon.
- He acknowledged that the optics may not look good in the short term. But he stressed the nuance of the situation and said he was committed to acting on principle rather than appearances.
- On Feb. 27, Altman relayed to a core group of staff that negotiations between the Pentagon and Anthropic had taken a turn for the worse due to the perception that Amodei was playing to the press.
⏰ Later that day, as the Pentagon's 5 p.m. deadline approached, Altman told the group that the Pentagon believed it could offer Anthropic an off-ramp from the supply chain risk designation.
- Altman remarked that he found it strange to be working so hard to "save" a rival whose CEO had, in his view, spent years trying to destroy OpenAI.
3. 💊 China threatens U.S. pharma

China's emergence as a second hub of pharmaceutical innovation could trigger massive changes to the global drug market, including how treatments are regulated and priced in the U.S., Axios' Caitlin Owens reports.
- Why it matters: More cutting-edge therapies are generally a good thing for patients, regardless of where they come from. But the new world order could spark questions over who'll access those therapies and where money flows.
🇨🇳 By the numbers: China went from being the country of origin for just 8% of the world's drug development in 2015 to 32.3% in 2024, according to a new study published yesterday in JAMA.
- 🇺🇸 The U.S., on the other hand, lost ground. In 2015, 48.2% of new programs originated here. By 2024, that number dropped to 37.4%.
- During that time, the number of U.S. drug development programs grew from around 5,000 to around 7,000 — but the Chinese programs skyrocketed from fewer than a thousand to more than 6,000.
🧑🏼🔬 Between the lines: The more China succeeds at getting drugs beyond early stages of development, the more likely it is that U.S. regulators will have to make tough decisions about how to evaluate the products.
- And Chinese companies could eventually compete with Western ones on price, undercutting today's lucrative financial model.
4. 🎬 Exclusive: Newsom on AI doom

California Gov. Gavin Newsom (D) told "The Axios Show" he doesn't believe AI will lead to an apocalypse for humanity.
- "I'm not a 'doomer.' I can't live like that," he told Axios' Alex Thompson at the Governor's Mansion in Sacramento this week.
"We have to manifest a brighter future," he said. "We're not victims. We're not bystanders. We can shape the future."
- "I also believe in guardrails. And I also believe in steering the debate, which we failed to do with social media," he added. "Let's not make the same mistakes with AI."
Newsom acknowledged that being called "slick" bothers him — but said that if he were to change to satisfy critics, "then I'm fake."
5. 🚨 New inflation warning

The OECD projects that U.S. inflation will edge up to 4.2% this year — up 1.2 percentage points from its previous forecast in December, Axios' Courtenay Brown writes.
- Why it matters: All over the world, a stabilizing inflation picture has been upended by the most severe global energy shock in decades.
📉 Wall Street suffered its worst losses yesterday since the war began, with the S&P 500 declining roughly 1.7%.
6. 🐘 MAGA stress tests
Three Republican primaries in May will test whether President Trump still holds an iron grip over the GOP — or whether cracks are emerging, Axios' Alex Isenstadt writes.
- Why it matters: Trump's approval rating has never been lower. The Iran war and the Epstein files have drawn backlash even within MAGA, straining one of the most loyal coalitions in American politics.
🔬 Zoom in: The White House is deeply involved in Trump's retribution campaigns across three state primaries next month.
- Indiana (May 5): Three pro-Trump groups are pouring more than $4 million into races to oust five GOP state legislators who defied Trump's redistricting demands.
- Louisiana (May 16): Trump has endorsed Rep. Julia Letlow's bid to unseat Sen. Bill Cassidy, targeting one of the few Republicans who voted to convict him after Jan. 6.
- Kentucky (May 19): Trump's political operation is deploying millions to take down Rep. Thomas Massie, a GOP renegade who led the push to release the Epstein files.
7. 🖊️ Trump to sign greenbacks

Since 1914 — 112 years ago — U.S. currency has carried the signatures of the Treasury Secretary and the U.S. treasurer. The Treasury Department announced yesterday that, for the first time, a sitting president's signature will appear on future U.S. paper currency alongside the Treasury secretary's, supplanting the treasurer, in honor of America's 250th birthday celebration. Go deeper.
- Last week, the U.S. Commission of Fine Arts approved a 24-karat gold commemorative coin bearing President Trump's image — also tied to the 250th anniversary. That cleared the way for the U.S. Mint to begin production. Go deeper.
🛠️ As Trump continues to reshape Washington's architecture, he has discussed turning the White House Treaty Room, on the second floor of the presidential residence, into a guest bedroom with an en suite bath, the N.Y. Times' Luke Broadwater and Maggie Haberman report.
8. 🌸 1 for the road: Sign of the times

National Guard members patrol amid cherry blossoms along the Tidal Basin in Washington yesterday.
- "Peak bloom" started yesterday and typically lasts 3-7 days.
👑 D.C. readers: Help crown a replacement for Stumpy, a beloved (albeit diminutive) cherry tree that fell victim to seawall repairs. Take the Axios poll.
📬 Thanks for reading! Please invite your friends to join AM.
Sign up for Axios AM




